Credit Suisse Ag Vaxcyte, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 123,970 shares of PCVX stock, worth $14.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

123,970

Previous 97,803 26.75%

Holding current value

$14.2 Million

Previous $6.14 Million 37.87%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$59.79 - $81.05 $1.56 Million - $2.12 Million	26,167 Added 26.75%	123,970 $8.47 Million
Q4 2023 Feb 08, 2024	BUY	$45.35 - $63.41 $525,651 - $734,985	11,591 Added 13.44%	97,803 $6.14 Million
Q3 2023 Nov 13, 2023	SELL	$46.0 - $53.1 $342,378 - $395,223	-7,443 Reduced 7.95%	86,212 $4.4 Million
Q2 2023 Aug 11, 2023	BUY	$34.66 - $54.07 $1.56 Million - $2.43 Million	44,984 Added 92.42%	93,655 $4.68 Million
Q1 2023 May 10, 2023	BUY	$36.27 - $47.2 $205,505 - $267,435	5,666 Added 13.18%	48,671 $1.82 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $279,167 - $650,441	13,565 Added 46.08%	43,005 $2.06 Million
Q3 2022 Nov 10, 2022	BUY	$21.69 - $28.53 $120,227 - $158,141	5,543 Added 23.2%	29,440 $706,000
Q2 2022 Aug 12, 2022	BUY	$17.68 - $26.58 $126,694 - $190,472	7,166 Added 42.83%	23,897 $520,000
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $6,268 - $9,463	-359 Reduced 2.1%	16,731 $405,000
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $74,652 - $102,202	3,864 Added 29.22%	17,090 $406,000
Q3 2021 Nov 12, 2021	BUY	$20.26 - $26.97 $38,818 - $51,674	1,916 Added 16.94%	13,226 $337,000
Q2 2021 Aug 16, 2021	SELL	$16.45 - $24.06 $28,491 - $41,671	-1,732 Reduced 13.28%	11,310 $254,000
Q1 2021 May 14, 2021	SELL	$18.66 - $29.16 $386,150 - $603,437	-20,694 Reduced 61.34%	13,042 $257,000
Q4 2020 Feb 12, 2021	BUY	$26.57 - $51.74 $896,365 - $1.75 Million	33,736 New	33,736 $895,000

Others Institutions Holding PCVX

# of Institutions

286

Shares Held

110M

Call Options Held

248K

Put Options Held

109K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $6.77B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account